Oppenheimer Boosts Addus HomeCare (NASDAQ:ADUS) Price Target to $145.00

Addus HomeCare (NASDAQ:ADUS) had its price objective boosted by analysts at Oppenheimer from $140.00 to $145.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s target price would indicate a potential upside of 8.79% from the stock’s current price.

Several other equities analysts also recently commented on the company. Macquarie initiated coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective on the stock. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. TD Cowen boosted their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $141.00 target price on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Finally, Stephens reissued an “overweight” rating and issued a $138.00 price target on shares of Addus HomeCare in a research report on Tuesday, August 6th. One equities research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $128.29.

Addus HomeCare Price Performance

ADUS opened at $133.29 on Monday. Addus HomeCare has a fifty-two week low of $78.35 and a fifty-two week high of $136.12. The company’s 50-day moving average is $127.53 and its 200 day moving average is $114.72. The firm has a market capitalization of $2.41 billion, a P/E ratio of 33.07, a PEG ratio of 2.33 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. Addus HomeCare’s revenue was up 10.4% on a year-over-year basis. During the same period last year, the business posted $0.94 earnings per share. On average, equities research analysts expect that Addus HomeCare will post 4.58 earnings per share for the current year.

Insider Buying and Selling

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the sale, the director now owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares of the company’s stock, valued at $502,695.98. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,917 shares of company stock worth $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

Institutional investors have recently added to or reduced their stakes in the business. UMB Bank n.a. increased its position in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the period. Quest Partners LLC bought a new position in Addus HomeCare during the 2nd quarter valued at approximately $31,000. Principal Securities Inc. purchased a new stake in Addus HomeCare in the 4th quarter worth approximately $26,000. Innealta Capital LLC bought a new stake in shares of Addus HomeCare in the 2nd quarter worth approximately $44,000. Finally, EntryPoint Capital LLC purchased a new position in shares of Addus HomeCare during the first quarter valued at approximately $44,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.